US Archives - Page 4 of 215 - European Medical Journal

Immunotherapy Super-Responders in Lung Cancer

Immune-checkpoint inhibitors (ICI) are an indispensable part of first-line treatment concepts for most patients with metastatic non-small…

Review of the American Society of Clinical Oncology (ASCO) Annual Meeting 2026

THE 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) returned to Chicago, Illinois, USA, from May 29–June 2…

EMJ

Our Latest Oncology Journal

The latest edition of AMJ Oncology is now live, distilling high-impact insights and the biggest breakthroughs from ASCO 2026 – spanning…

AMJ Oncology 3.1 2026

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting delivered practice-shaping oncology data across pancreatic…

HER2-Positive Early Breast Cancer: Key Updates from ASCO 2026

Updates on the evolving treatment landscape in HER2+ eBC presented at ASCO 2026, highlighting the role of trastuzumab deruxtecan…

Advancing Care in Metastatic Breast Cancer

The treatment landscape continues to evolve for patients with ER+/HER2– mBC. In this video, Seth Wander and Jennifer Caudle review two…

p53 Antibodies May Predict NSCLC Response

Cancer immunotherapy has transformed outcomes for patients with advanced non-small cell lung cancer (NSCLC), enabling long-term survival…

ASCO 2026: Highlights in Breast Cancer Research

The American Society of Clinical Oncology (ASCO) 2026 Annual Meeting delivered a broad and scientifically rigorous breast cancer…

Multi-Cancer Early Detection Test for Population Screening

PATHFINDER 2 and NHS-Galleri population-scale studies show that a multi-cancer early detection (MCED) blood test increased screen-detected…

ASCO 2026 Interview: Elizabeth Mittendorf

I like to suggest that I was into immunotherapy before it became cool. When I was serving in the military, after I finished my surgical…